Reduced expression of FBXO7, a component of the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligase complex, occurs in about one-third of CRCs and correlates with CIN, positioning FBXO7 as a potential therapeutic target. This evidence concerns the gene FBXO7 and cervical squamous intraepithelial neoplasia.